| Product Code: ETC6181704 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The glanders treatment market in Australia remains niche, given the rare occurrence of the disease, which primarily affects horses and other equines. However, stringent biosecurity protocols and veterinary pharmaceutical advancements ensure preparedness in the event of an outbreak. Research and development are driven by the potential bioterrorism threat posed by glanders, with government and defense institutions involved in preparedness strategies. Antibacterial drugs and diagnostic services form the core of this market.
The glanders treatment market in Australia remains niche but is witnessing growing attention due to biosecurity concerns and awareness around zoonotic diseases. The trend is leaning towards developing more robust diagnostic and therapeutic measures, including the adoption of advanced antibiotics and novel treatment protocols. Additionally, government surveillance programs and research on bioterrorism threats are contributing to a renewed focus on glanders management.
The treatment market for glanders, a bacterial infection affecting both animals and humans, faces a significant challenge in terms of the availability of effective treatments. Glanders is rare but highly contagious, and it often results in severe outbreaks in specific industries, particularly in equestrian and livestock. However, the treatment options are limited, with a heavy reliance on antibiotics that may have resistance issues. Furthermore, the complexity of diagnosing glanders and the need for specialized veterinary care in remote areas adds to the difficulties. The lack of widespread public awareness about the disease also hampers efforts to prevent outbreaks, and biosecurity protocols need to be constantly reinforced.
The Australia glanders treatment market represents an emerging sector due to the growing awareness and need for veterinary solutions related to glanders, a zoonotic disease that affects livestock. Investment in this market could focus on the development of vaccines, diagnostic tools, and treatments for glanders, particularly as regulations around animal health become stricter. With increasing concerns over animal diseases and their impact on the agriculture industry, there is room for growth in developing effective treatments and preventive measures, opening opportunities for companies specializing in veterinary pharmaceuticals.
In Australia, the treatment and control of glanders, a bacterial infection primarily affecting equines, is governed by strict biosecurity regulations. The Australian Government Department of Agriculture, Fisheries and Forestry (DAFF) plays a central role in monitoring and controlling the disease. Policies include mandatory testing of animals and quarantine procedures to prevent outbreaks. Additionally, veterinary treatments and vaccines for glanders are subject to government approval, and there is a focus on research funding for more effective treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Glanders Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Glanders Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Glanders Treatment Market - Industry Life Cycle |
3.4 Australia Glanders Treatment Market - Porter's Five Forces |
3.5 Australia Glanders Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Australia Glanders Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Glanders Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about glanders disease in Australia |
4.2.2 Advancements in medical research leading to improved treatment options |
4.2.3 Government initiatives promoting animal health and disease prevention |
4.3 Market Restraints |
4.3.1 Limited availability of specialized treatment facilities for glanders |
4.3.2 High treatment costs impacting accessibility for some farmers |
4.3.3 Regulatory challenges affecting the approval process for new treatments |
5 Australia Glanders Treatment Market Trends |
6 Australia Glanders Treatment Market, By Types |
6.1 Australia Glanders Treatment Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Australia Glanders Treatment Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Australia Glanders Treatment Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.1.4 Australia Glanders Treatment Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.1.5 Australia Glanders Treatment Market Revenues & Volume, By Streptomycin, 2021- 2031F |
6.1.6 Australia Glanders Treatment Market Revenues & Volume, By Novobiocin, 2021- 2031F |
6.1.7 Australia Glanders Treatment Market Revenues & Volume, By Gentamicin, 2021- 2031F |
6.2 Australia Glanders Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Australia Glanders Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Australia Glanders Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.4 Australia Glanders Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 Australia Glanders Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.6 Australia Glanders Treatment Market Revenues & Volume, By Glander, 2021- 2031F |
7 Australia Glanders Treatment Market Import-Export Trade Statistics |
7.1 Australia Glanders Treatment Market Export to Major Countries |
7.2 Australia Glanders Treatment Market Imports from Major Countries |
8 Australia Glanders Treatment Market Key Performance Indicators |
8.1 Number of reported cases of glanders in Australia |
8.2 Adoption rate of new treatment methods among veterinarians |
8.3 Funding allocated towards research and development of glanders treatments |
9 Australia Glanders Treatment Market - Opportunity Assessment |
9.1 Australia Glanders Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Australia Glanders Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Glanders Treatment Market - Competitive Landscape |
10.1 Australia Glanders Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Glanders Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here